OpenBilldrug price receipt

NADAC week of 2026-10-14

ATOVAQUONE 750 MG/5 ML SUSP CUP

For 210 mL

Pharmacies pay

$161.04 filed

210 × $0.76684 per ML

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$344.58 filed

210 × $1.64086 per ML, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.1× estimated

Medicare paid 2.1× what pharmacies pay.

Part D averages every strength and form sold under “Atovaquone” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$190.20 estimated

$161.04 + $24.16 (15%) + $5.00 fee per fill = $190.20

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ATOVAQUONE 750 MG/5 ML SUSP CUP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “atovaquone” and “atovaquone oral suspension”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as suspension and its route as oral.

Its labelers, the companies named on the label, are Major Pharmaceuticals and Kesin Pharma.

FDA lists it under 2 Established Pharmacologic Classes: Antimalarial and Antiprotozoal.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $161.04 for 210 mL (210 × $0.76684 per ML, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 5, calculated based on package size.

All 3 NDCs

Other strengths, forms and brands

2 other products in the NADAC file share an FDA nonproprietary name with ATOVAQUONE 750 MG/5 ML SUSP CUP.

ProductPharmacies pay per unitMedicare per unit
ATOVAQUONE 750 MG/5 ML SUSP
generic · suspension
$0.76684 per ML filed
eff. 2026-09-23
$1.64086 per ML filed
Part D 2024 average
ATOVAQUONE 750 MG/5 ML SUSP CUP this page
generic · suspension
$0.76684 per ML filed
eff. 2026-09-23
$1.64086 per ML filed
Part D 2024 average
ATOVAQUONE 750 MG/5 ML SUSPENSION CUP
generic · suspension
$0.76684 per ML filed
eff. 2026-09-23
$1.64086 per ML filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $344.58 for 210 mL, at an average of $1.64086 per ML in 2024 (2024-01-01 to 2024-12-31) for “Atovaquone”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 87,458 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ATOVAQUONE 750 MG/5 ML SUSP CUP labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Atovaquone / Atovaquone: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's ML. Joined on generic name.
Why does this page start at 210 mL?
NADAC prices this product per ML. The FDA NDC Directory’s package description gives 210 mL in one package for all 3 NDCs of this product (“7 TRAY in 1 CASE (0904-7459-53) / 6 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0904-7459-41)”), so the card starts at one package: 210 ML. Change it to match your prescription.